Brief: BetterLife Pharma Says Entered Into Exclusivity Agreement With Altum Pharmaceuticals
11/06/2020 12:20
June 11 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE PHARMA UPDATES SHAREHOLDERS ON ITS PROPOSED
ACQUISITION OF ALTUM
* BETTERLIFE PHARMA INC - ENTERED INTO AN EXCLUSIVITY
AGREEMENT
WITH ALTUM PHARMACEUTICALS INC.
* BETTERLIFE PHARMA INC - AMENDED MAY 6 ALTUM DEAL TERMS TO
ACQUIRE WORLDWIDE RIGHTS TO COMMERCIALIZE, SELL AP-003,
POTENTIAL COVID-19 TREATMENT
Source text for Eikon: ID:nCNWC4Cw5a
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Goldhaven Resources
See all newsBrief: GoldHaven Announces Phase II Drill Program at Copeçal as Independent Review Identifies Multiple Mineralization Vectors
Advisory: Alert from American News Group commentary tagged to multiple companies withdrawn
Brief: Goldhaven Upsizes Flow-Through Financing To Up To $1.2 Million On Strong Demand To Expand 2026 Drill Program At Magno
Brief: Goldhaven Closes $1.72 Million First Tranche Flow-Through Financing To Fund 2026 Drill Program Targeting High-Grade At Magno Project
Brief: Goldhaven Resources Completes Diamond Drilling At Copeçal Gold Project